Andrea Molckovsky

Latest papers

Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
New England Journal of Medicine · 2025
Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial
npj Breast Cancer · 2021
Serum metabolomic profile as a means to distinguish stage of colorectal cancer
Genome Medicine · 2012

All 28 publications

28 publications.

01

Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer

Campone M, De Laurentiis M, Jhaveri K, Hu X, Ladoire S, Patsouris A, Zamagni C, Cui J, Cazzaniga M, Cil T

New England Journal of Medicine2025165 citations

DOI: 10.1056/nejmoa2505725

02

Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial

Goodwin PJ, Dowling RJO, Ennis M, Chen BE, Parulekar WR, Shepherd LE, Burnell MJ, Vander Meer R, Molckovsky A, Gurjal A

npj Breast Cancer202125 citations

DOI: 10.1038/s41523-021-00275-z

03

Serum metabolomic profile as a means to distinguish stage of colorectal cancer

Farshidfar F, Weljie AM, Kopciuk K, Buie WD, MacLean A, Dixon E, Sutherland FR, Molckovsky A, Vogel HJ, Bathe OF

Genome Medicine2012107 citations

DOI: 10.1186/gm341

04

Characterization of published errors in high-impact oncology journals

Molckovsky A, Vickers MM, Tang PA

Current Oncology201129 citationsFirst author

DOI: 10.3747/co.v18i1.707

05

Approach to inflammatory breast cancer.

Molckovsky A, Fitzgerald B, Freedman O, Heisey R, Clemons M

Canadian Family Physician200928 citationsFirst author

06

Characterization of published errors in high-impact oncology journals

Molckovsky A, Vickers MM, Tang PA

Journal of Clinical Oncology2009First author

DOI: 10.1200/jco.2009.27.15_suppl.6627

07

Characterization of published errors in high-impact oncology journals

Molckovsky A, Vickers MM, Tang PA

Journal of Clinical Oncology2009First author

08

First-in-class, first-in-human phase I results of targeted agents: Highlights of the 2008 American Society of Clinical Oncology meeting

Molckovsky A, Siu LL

Journal of Hematology and Oncology2008139 citationsFirst author

DOI: 10.1186/1756-8722-1-20

09

Breast cancer in pregnancy: a literature review

Molckovsky A, Madarnas Y

Breast Cancer Research and Treatment200858 citationsFirst author

DOI: 10.1007/s10549-007-9616-6

10

Decreased dose density of standard chemotherapy does not compromise survival for ovarian cancer patients

Molckovsky A, Vijay SM, Hopman WM, Bryson P, Jeffrey JF, Biagi JJ

International Journal of Gynecological Cancer20082 citationsFirst author

DOI: 10.1111/j.1525-1438.2007.00990

Frequent collaborators

Timothy Whelan

Oncology

1 shared papers, latest 2021

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student Dear Professor Molckovsky, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer" (2025), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Open in email